Skip to main content
. 2023 Jan 9;13:1106260. doi: 10.3389/fphar.2022.1106260

FIGURE 3.

FIGURE 3

The pharmacological mechanisms of rhein in improving IR in DM by inhibiting HBP overactivity. PAGM, Phosphoacetllucosaminemutase; ATP, adenosine triphosphate; ADP, adenosine diphosphate; UDP, uridine diphosphate; UTP, uridine triphosphate.